Microarray News and Research

RSS

OGT launches high-quality NGS panel for research into Chronic Lymphocytic Leukemia

Oxford Gene Technology, A Sysmex Group Company, is excited to announce the launch of its SureSeq CLL + CNV Panel — the company’s latest high-quality, next-generation sequencing offering for research into Chronic Lymphocytic Leukaemia.

From Oxford Gene Technology 16 Jan 2020

A new book on ovarian cancer

An opening discussion of contemporary management of this disease presents commentary on surgery and clinical trials: neoadjuvant, dose-dense, and heated intraperitoneal chemotherapy (HIPEC}, as well as immunotherapy, vaccine therapy, emerging therapies.

18 Dec 2019

Arrayjet secures new contract to provide SciLifeLab with microarray technology for proteomics research

Arrayjet, the Scottish-based microarray instrumentation company, has secured a GBP250,000 contract to provide the Swedish SciLifeLab - the national hub for molecular bioscience in Sweden - with microarray technology to provide further analytical information for mapping the human protein atlas.

29 Nov 2019

Scientists move closer towards developing an effective malaria vaccine

Scientists have taken another big step forward towards developing a vaccine that’s effective against the most severe forms of malaria.

13 Nov 2019

Breast cancer could soon be detected early using a blood test

Researchers have found that breast cancer may be successfully detected up to five years before any symptoms appear using a blood test. The results of this land mark study which could mean diagnosis of breast cancer early and treating it more effectively, were presented at the 2019 NCRI Cancer Conference Sunday (3rd November 2019).

4 Nov 2019

IDT launches high quality, ready-to-use custom oligo pools

Continuing its mission to advance biological research worldwide, Integrated DNA Technologies has launched oPools Oligo Pools – ready-to-use pools of high quality DNA oligonucleotides (oligos) up to 350 nucleotides in length.

From Integrated DNA Technologies 16 Aug 2019

Genesis Healthcare announces launch of new wellness mobile application

Genesis Healthcare Co., Japan's leading genetic testing and research company, today announced the launch of its new mobile application in Singapore, empowering its new and existing GeneLife users to access personal genetic results on their mobile and receive personalized wellness advice and recommendations to enhance their health and lifestyle.

31 Jul 2019

Study examines role of plastic exposure in irregular heart rhythms, arrhythmias

Calling an ambulance during an emergency, emailing a breaking news or journal article before a 5 p.m. deadline and maintaining conditions during the fifth week of a 6-week lab study, without altering the light or temperature, requires electricity and translates into time, money and lives

22 Jul 2019

Innovative single-chip platform speeds up drug development process

Scientists at the Karlsruhe Institute of Technology (KIT) have come up with a miniaturized and accelerated system of new drug development on just one chip, promising to make the process faster and cheaper than ever before. The report was published in the journal Nature Communications on June 28, 2019.

16 Jul 2019

Comprehensive gene activity database could significantly reduce animal use

A comprehensive database of gene activity in mice across ten disease models, which could significantly reduce animal use worldwide, has been developed by scientists at the Francis Crick Institute, which gives a full picture of the immune response to different pathogens.

29 Jun 2019

Biomarker correlates with prostate cancer aggressiveness and predicts metastasis to bone

Mortality due to prostate cancer is usually related to its likelihood to metastasize, especially to bone. Prognostic biomarkers are urgently needed to predict disease aggression so that appropriate treatment can be selected.

12 Jun 2019

TTP partners with Quotient to transform transfusion diagnostics and beyond

TTP plc, a leading independent technology and product development company, has announced today that it has partnered with Quotient Ltd, a commercial-stage diagnostics company committed to transforming transfusion diagnostics and beyond – to develop and implement a state-of-the-art manufacturing facility for Quotient's proprietary MosaiQTM system.

From TTP plc 21 May 2019

Radiation-induced vascular damage could be treated with IL-1 inhibitors

Radiation therapy against cancer can increase the risk of cardiovascular disease much later in life, as the radiation causes chronic inflammation of the exposed blood vessels.

14 May 2019

Researchers use genomics to solve a 20-year case study

After 20 years, a patient's family received an answer to a decades-long genetic mystery. Their daughter had two rare disorders, Angelman syndrome and P450scc deficiency, which was detected after researchers found out she had uniparental disomy, two copies of chromosome 15 from one parent and none from another.

28 Apr 2019

New sepsis detector uses photonics to make accurate diagnosis in less than thirty minutes

European scientists have developed a new sepsis detector that uses photonics to produce a while-you-wait diagnosis, from sample to result, in less than thirty minutes.

24 Apr 2019

New scoring system based on genetic markers predicts obesity risk at birth

Researchers have come up with a scoring system based on genetic markers that predicts an individual's inborn risk for obesity.

19 Apr 2019

New study explains why heart failure patients have trouble with thinking and depression

Heart failure patients often have trouble with thinking and depression. A new study by University of Guelph researchers explains why and points to ways to prevent and treat both heart and brain maladies through the emerging field of circadian medicine.

5 Apr 2019

Study offers novel insights into how a major tumor suppressor pathway becomes deactivated

The Hippo pathway is an important biological tumor suppressor program that controls cell growth and organ size in humans.

5 Apr 2019

Tobacco use causes precancerous cells to 'fertilize' nearby cells with cancerous changes

Tobacco use causes a field of precancerous cells, increasing the risk of developing head & neck cancer. But exactly how this precancerous field influences cancer has been often overlooked.

2 Apr 2019

Anti-inflammatory drug shown to promote cardiac reprogramming

Once damaged, the human heart does a poor job of repairing itself, so this is a key priority for treating heart failure. One way of restoring cardiac function is to reprogram non-cardiac body cells such as fibroblasts into heart muscle cells (cardiomyocytes) using a collection of cardiac transcription factors.

6 Mar 2019